<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immune stimulation &#8211; MicrobiomePost</title>
	<atom:link href="https://microbiomepost.com/functionality/immune-stimulation/feed/" rel="self" type="application/rss+xml" />
	<link>https://microbiomepost.com</link>
	<description></description>
	<lastBuildDate>Thu, 12 Feb 2026 16:08:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.5</generator>

<image>
	<url>https://microbiomepost.com/wp-content/uploads/2025/03/cropped-Favicon_MBP-1-32x32.png</url>
	<title>Immune stimulation &#8211; MicrobiomePost</title>
	<link>https://microbiomepost.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Lactobacillus gasseri LMG P-30998</title>
		<link>https://microbiomepost.com/probiotic-strains/lactobacillus-gasseri-lmg-p-30998/</link>
		
		<dc:creator><![CDATA[Marco Marino]]></dc:creator>
		<pubDate>Wed, 16 Jul 2025 10:47:47 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomepost.com/?post_type=probiotic-strains&#038;p=27049</guid>

					<description><![CDATA[The strain was tested in vitro for the following features]]></description>
										<content:encoded><![CDATA[
<ul class="wp-block-list">
<li>Strain isolated from feces from babies</li>



<li>Strain safe for human use: genome sequence (WGS) and safety data (antibiotic sensitivity) are available</li>



<li>Strain subjected to EU patent application and PCT</li>



<li>Strain stability in liofilized powder form available over 6 months</li>
</ul>



<h3 class="wp-block-heading">The strain was tested in vitro for the following features</h3>



<ol class="wp-block-list">
<li>the strain is sensitive to 9 antibiotics according to EFSA standards</li>



<li>the strain adheres to the Caco-2 epithelial intestinal cells</li>



<li>the strain is able to ferment prebiotics (FOS, IMO and lactulose)</li>



<li>the strain has antipathogenic activity, adhesive ability to intestinal cells, it survives the gastric and intestinal transit</li>



<li>the strain is able to activate the immune system to prevent possible viral infection: in its viable forms it induces IL-12p70 secretion in PBMCs</li>
</ol>



<p></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Bifidobacterium breve LMG P-30999</title>
		<link>https://microbiomepost.com/probiotic-strains/bifidobacterium-breve-lmg-p-30999/</link>
		
		<dc:creator><![CDATA[Marco Marino]]></dc:creator>
		<pubDate>Tue, 15 Jul 2025 11:57:58 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomepost.com/?post_type=probiotic-strains&#038;p=27047</guid>

					<description><![CDATA[The strain was tested in vitro for the following features]]></description>
										<content:encoded><![CDATA[
<ul class="wp-block-list">
<li>Strain isolated from feces from babies</li>



<li>Strain safe for human use: genome sequence (WGS) and safety data (antibiotic sensitivity) are available</li>



<li>Strain subjected to EU patent application and PCT</li>



<li>Strain stability in liofilized powder form available over 6 months</li>
</ul>



<h3 class="wp-block-heading">The strain was tested in vitro for the following features</h3>



<ol class="wp-block-list">
<li>the strain is sensitive to 9 antibiotics according to EFSA standards</li>



<li>the strain adheres to the Caco-2 epithelial intestinal cells</li>



<li>the strain is able to ferment prebiotics (FOS, raffinose and lactulose)</li>



<li>the strain has antipathogenic activity and adhesive ability to intestinal cells, it survives the gastric and intestinal transit</li>



<li>the strain has immunomodulatory properties: it activates dendritic cells, stimulates CD86 and CD40 markers, promotes expression of MHC I and II that support mucolase and systemic immunity</li>



<li>the stain is able to to induce a two-fold induction in GLP-1 secretion in human L-cells (antidiabetogenic potential)</li>
</ol>



<p></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Synbiotics by Probi® and Clasado</title>
		<link>https://microbiomepost.com/probiotic-blends/synbiotics-by-probi-and-clasado/</link>
		
		<dc:creator><![CDATA[GiovanniAdmin]]></dc:creator>
		<pubDate>Wed, 20 Dec 2023 14:39:45 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=probiotic-blends&#038;p=22593</guid>

					<description><![CDATA[Synbiotics by Probi and Clasado combines the most researched probiotic strains with the most comprehensively studied galactooligosaccharide (GOS) prebiotic available on the market. Bimuno® GOS is supported by over 110 publications, including 20+ clinical trials, while Probi Digestis® and Probi Defendum® boasts over 250 publications, including 80+ clinical trials. These synbiotic concepts represent truly scientifically [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>Synbiotics by Probi and Clasado combines the most researched probiotic strains with the most comprehensively studied galactooligosaccharide (GOS) prebiotic available on the market. Bimuno® GOS is supported by over 110 publications, including 20+ clinical trials, while Probi Digestis® and Probi Defendum® boasts over 250 publications, including 80+ clinical trials. These synbiotic concepts represent truly scientifically backed combinations, offering either a unique and novel gut health position, or, an overall gut-immune concept.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>SynbÆctive® ProBeautyShield</title>
		<link>https://microbiomepost.com/probiotic-blends/probeautyshield/</link>
		
		<dc:creator><![CDATA[GiovanniAdmin]]></dc:creator>
		<pubDate>Fri, 08 Sep 2023 11:06:43 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=probiotic-blends&#038;p=21963</guid>

					<description><![CDATA[ProBeautyShield, a probiotic complex developed by SynBalance, is formulated to support overall skin health—particularly in individuals with atopic dermatitis and acne-prone skin—and to enhance skin appearance by reducing wrinkles in mature skin. Its effectiveness has been confirmed through five randomized, double-blind, placebo-controlled clinical trials. The first trial focused on atopic dermatitis, while two additional studies [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>ProBeautyShield, a probiotic complex developed by SynBalance, is formulated to support overall skin health—particularly in individuals with atopic dermatitis and acne-prone skin—and to enhance skin appearance by reducing wrinkles in mature skin. Its effectiveness has been confirmed through five randomized, double-blind, placebo-controlled clinical trials. The first trial focused on atopic dermatitis, while two additional studies investigated acne in different populations (Caucasian and Chinese subjects), all showing significant improvements in skin condition. The remaining two trials targeted mature skin, demonstrating visible anti-aging benefits, including reduced wrinkles, enhanced radiance, and improved skin firmness and elasticity.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>SynbÆctive® Femme</title>
		<link>https://microbiomepost.com/probiotic-blends/femme/</link>
		
		<dc:creator><![CDATA[GiovanniAdmin]]></dc:creator>
		<pubDate>Fri, 08 Sep 2023 11:06:31 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=probiotic-blends&#038;p=21962</guid>

					<description><![CDATA[Femme is a probiotic complex by SynBalance, specifically designed to support women’s intimate health. Clinically tested in 3 clinical trials, it confirmed the strains ability to colonize the vagina, as well as its effectiveness in supporting vaginal health against bacterial vaginosis and in post-menopausal women. In particular, Femme was able to reduce BV relapses and [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>Femme is a probiotic complex by SynBalance, specifically designed to support women’s intimate health. Clinically tested in 3 clinical trials, it confirmed the strains ability to colonize the vagina, as well as its effectiveness in supporting vaginal health against bacterial vaginosis and in post-menopausal women. In particular, Femme was able to reduce BV relapses and symptoms, and to lower inflammation while restoring vaginal microbiota in menopause.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>SynbÆctive® AllergAway</title>
		<link>https://microbiomepost.com/probiotic-blends/allergaway/</link>
		
		<dc:creator><![CDATA[GiovanniAdmin]]></dc:creator>
		<pubDate>Fri, 08 Sep 2023 11:06:01 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=probiotic-blends&#038;p=21959</guid>

					<description><![CDATA[AllergAway is a probiotic complex by SynBalance, specifically designed to support our body natural defenses during seasonal allergies. A randomized, double-blind, placebo-controlled trial on subjects with allergic rhinitis showed that AllergAway improved quality of life, reduced allergic rhinitis symptoms, and modulated immune markers and gut microbiota diversity, demonstrating its immunomodulatory potential and effectiveness during allergy [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>AllergAway is a probiotic complex by SynBalance, specifically designed to support our body natural defenses during seasonal allergies. A randomized, double-blind, placebo-controlled trial on subjects with allergic rhinitis showed that AllergAway improved quality of life, reduced allergic rhinitis symptoms, and modulated immune markers and gut microbiota diversity, demonstrating its immunomodulatory potential and effectiveness during allergy season.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Bifidobacterium longum subsp. infantis BI221 (LMG P-29639)</title>
		<link>https://microbiomepost.com/probiotic-strains/bifidobacterium-longum-subsp-infantis-bi221-lmg-p-29639/</link>
		
		<dc:creator><![CDATA[GiovanniAdmin]]></dc:creator>
		<pubDate>Fri, 08 Sep 2023 10:51:57 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=probiotic-strains&#038;p=21955</guid>

					<description><![CDATA[Bifidobacterium longum subsp. infantis BI221 (LMG P-29639), developed by SynBalance.Gastrointestinal Health • Immune prevention]]></description>
										<content:encoded><![CDATA[
<p><em>Bifidobacterium longum</em> subsp. <em>infantis</em> BI221 (LMG P-29639), developed by SynBalance.<br>Gastrointestinal Health • Immune prevention</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Lactiplantibacillus plantarum PBS067 (DSM 24937)</title>
		<link>https://microbiomepost.com/probiotic-strains/lactiplantibacillus-plantarum-pbs067-dsm-24937/</link>
		
		<dc:creator><![CDATA[GiovanniAdmin]]></dc:creator>
		<pubDate>Fri, 08 Sep 2023 10:45:34 +0000</pubDate>
				<guid isPermaLink="false">https://microbiome-hub.com/?post_type=probiotic-strains&#038;p=21947</guid>

					<description><![CDATA[Lactiplantibacillus plantarum PBS067 (DSM 24937), developed by SynBalance.Gastrointestinal Health • Urogenital health • Metabolic Health • Skin Health • Immune prevention ]]></description>
										<content:encoded><![CDATA[
<p><em>Lactiplantibacillus plantarum</em> PBS067 (DSM 24937), developed by SynBalance.<br>Gastrointestinal Health • Urogenital health • Metabolic Health • Skin Health • Immune prevention </p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Probi® Osteo</title>
		<link>https://microbiomepost.com/probiotic-blends/probi-osteo/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Thu, 15 Dec 2022 16:38:18 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomehub.videe.co/probiotic-blends/probi-osteo/</guid>

					<description><![CDATA[Probi® Osteo is based on a combination of three probiotic strains, Lactiplantibacillus plantarum HEAL9 (HEAL9™), Lactiplantibacillus plantarum HEAL19 and Lacticaseibacillus paracasei 8700:2 (L. paracasei 8700:2™), equally contributing to the clinically documented dose of 10 billion (10 B) CFU per day. Results from studies have shown that the combination of the three strains have an impact [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>Probi® Osteo is based on a combination of three probiotic strains, <a href="https://microbiomepost.com/probiotic-strains/lactiplantibacillus-plantarum-heal9-heal9/">Lactiplantibacillus plantarum HEAL9</a> (HEAL9™), Lactiplantibacillus plantarum HEAL19 and Lacticaseibacillus paracasei 8700:2 (L. paracasei 8700:2™), equally contributing to the clinically documented dose of 10 billion (10 B) CFU per day. Results from studies have shown that the combination of the three strains have an impact on bone turnover by decreasing resorption of bones. The effects of Probi® Osteo on bone health have also been investigated in early postmenopausal women.</p>
<p>Probi® Osteo is a registered trademark of Probi AB.</p>
<p>Watch the probiotic mode of action of Probi® Osteo:<br />
<iframe title="YouTube video player" src="https://www.youtube.com/embed/OJhLqZKKziE" width="560" height="315" frameborder="0" allowfullscreen="allowfullscreen"></iframe></p>
<p><strong>Probiotic strains present in the blend/product</strong></p>
<ul>
<li>Lactiplantibacillus plantarum HEAL9 (HEAL9™) (DSM 15312)</li>
<li>Lactiplantibacillus plantarum HEAL19 (DSM 15313)</li>
<li>Lacticaseibacillus paracasei 8700:2 (L. paracasei 8700:2™) (DSM 13434)</li>
</ul>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Lacticaseibacillus rhamnosus 6594  (Probi® Rhamnosus 6594)</title>
		<link>https://microbiomepost.com/probiotic-strains/lacticaseibacillus-rhamnosus-6594/</link>
		
		<dc:creator><![CDATA[Staff]]></dc:creator>
		<pubDate>Mon, 05 Dec 2022 16:21:30 +0000</pubDate>
				<guid isPermaLink="false">https://microbiomehub.videe.co/?post_type=probiotic-strains&#038;p=18591</guid>

					<description><![CDATA[Several studies have shown that Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) can survive and persist in the gastrointestinal tract in humans. The strain was even recovered in the faeces in nearly all subjects up to 15 days after administration. Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) has been shown to support the immune system, as well [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>Several studies have shown that <em>Lacticaseibacillus rhamnosus</em> 6594 (Probi® Rhamnosus 6594) can survive and persist in the gastrointestinal tract in humans. The strain was even recovered in the faeces in nearly all subjects up to 15 days after administration. <em>Lacticaseibacillus rhamnosus</em> 6594 (Probi® Rhamnosus 6594) has been shown to support the immune system, as well as improve general gut and overall health status in children as young as 11 days of age, up to adults.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
